Lv1
40 积分 2025-08-01 加入
Efficacy and multi-omics regulatory effects of guilou tongluo formula in patients with chronic obstructive pulmonary disease combined with pulmonary hypertension: a prospective, multicenter, randomized controlled trial
2个月前
已完结
Disproportionate impairment in diffusing capacity predicts pulmonary hypertension with an elevated pulmonary vascular resistance in COPD
2个月前
已完结
Cardiac damage and outcome in transcatheter aortic valve replacement patients-a COMPARE-TAVI 1 trial sub-study
2个月前
已关闭
Association of Phosphodiesterase-5 Inhibitor Treatment With Improved Survival in Pulmonary Hypertension Associated With COPD in the Pulmonary Vascular Research Institute GoDeep Meta-Registry
2个月前
已完结
Analyzing the molecular mechanism of xuefuzhuyu decoction in the treatment of pulmonary hypertension with network pharmacology and bioinformatics and verifying molecular docking
2个月前
已完结
Platelets as drivers of immunothrombosis in rheumatic diseases
3个月前
已完结
Current concepts and novel targets for antiplatelet therapy
3个月前
已完结
Deciphering opsonized zymosan–induced phosphorylation of p47phox and NADPH oxidase activation in human neutrophils
3个月前
已关闭
NADPH oxidase family proteins: signaling dynamics to disease management
3个月前
已完结
Potential drivers of EndMT in pulmonary arteries of patients with early COPD
3个月前
已关闭
皖公网安备34019202002308
